FDA Issues Emergency Use Authorization to Decontaminate Millions of N95 Respirators

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Advanced Sterilization Products (ASP) for the STERRAD Sterilization Cycles that has the potential to decontaminate approximately 4 million N95 or N95-equivalent respirators per day in the U.S. for single-user reuse by health care workers in hospital settings.

This authorization will help increase the availability of respirators so health care workers on the front lines can be better protected and provide the best care to patients with COVID-19.